Skip to main content
. 2010 Jan 27;10:27. doi: 10.1186/1472-6963-10-27

Figure 1.

Figure 1

Design and development of core measure for colorectal cancer. *members of research team included KPC, SHC, LTC, RT, TWL, MJS and a scholar, #twenty expert were invited (research team member excluded), see also the expert panel in Appendix, 1 including 37 structure indicators, 78 process indicators, and 7 outcome indicators, 2 including 9 structure indicators, 37 process indicators, and 4 outcome indicators, 3including 4 pre-treatment indicators, 21 treatment indicators, and 5 monitor indicators, 4including 3 pre-treatment indicators, 16 treatment indicators, and 6 monitor indicators, 5including 2 pre-treatment indicators, 16 treatment indicators, and 6 monitor indicators, 6including 1 pre-treatment indicator, 11 treatment indicators, and 5 monitor indicators, 7hospitals and clinical professionals are major stakeholders, 8questionnaires were mailed on August 16, 2004, response rate 95% (19/20), 9 expert meeting was held in Taipei, September 22, 2004, 10 questionnaires were mailed on October 26, 2004, response rate 85% (17/20), 11 1st symposium was held in Taipei, December 27, 2005, 12 2nd symposium was held in Taipei, March 27, 2006.